State Bank of India (SBI) Quarter(Q4) Result Update:

SBI today reported 23 per cent jump in standalone net profit at Rs 3,742.02 crore in the fourth quarter ended March 2015 on improvement in its asset quality. State Bank of India 's March quarter earnings have beaten estimates with net profit rising 23.1 percent to Rs 3742 crore from Rs 3040.7 crore in corresponding quarter last quarter. Net interest income (NII), during the quarter rose 14 percent to Rs 14,712 crore compared to Rs 12,903 crore year-on-year (Y-o-Y).

The country's largest bank had made a net profit of Rs 3,040.74 crore during the same quarter a year ago.Total income of the bank also increased to Rs 48,616.41 crore in the last quarter of FY15, from Rs 42,443.27 crore in the same quarter a year ago, State Bank of India (SBI) said in a filing to the BSE.

Though  asset quality has seen big improvement it was aided by sale of loans to Asset Reconstruction Companies (ARCS). Sale of loans to ARCs increased to Rs 4510 crore against no amount in last quarter. Write offs was at Rs 4874 crore versus Rs 5096 crore while recoveries stood at Rs 4485 crore. Home loans increased from Rs 1,40,738 crore in March’14 to Rs 1,59,237 crore in March’15 (13.14 percent).

During January-March quarter of 2014-15, the bank's asset quality improved as net non-performing assets (NPAs) or bad loans were trimmed to 2.12 per cent of net advances as against 2.57 per cent at the end of previous fiscal.

At the same time, gross NPAs also came down to 4.25 per cent of gross advances, from 4.95 per cent at the end of March 2014.During the quarter, total provisioning and contingencies of the bank were high at Rs 6,592.91 crore from Rs 5,891.12 crore a year ago.

For the entire fiscal ended March 2015, SBI's net profit increased 20 per cent to Rs 13,101.57 crore as compared to Rs 10,891.17 crore for the year ended March 2014.Total income on a standalone basis increased to Rs 1,74,972.96 crore from Rs 1,54,903.72 crore for the year ended March 2014.

The bank has recommended a dividend of 350 per cent or Rs 3.50 per share for the year ended March 2015.

Stock analysis: TTK Prestige (TTKPRESTIG) Profit update

On 7 th March we have posted  the TTK Prestige (TTKPRESTIG)  stock update. And advised to buy this stock when it comes to 3250 level.On 27 th March Low was 3140. so my buy level has reached.

In that post we have strongly recommended to buy this stock at 3250 and first target is 3900 and final target is 4000. And it crossed my target level i,e 4000.

Today high is 4048.

Please find below the link for that post

http://nseanalyst.blogspot.de/2015/03/stock-analysis-ttk-prestige-ttkprestig.html

Further if you need any shares analysis in your mind or you are considering to trade them intraday or if you want to get invested in these shares for short term and long term, approach me. Whenever I get a time I would analyze them  and would provide entry and/or exit level in this blog itself.

Stocks to watch update on 19 may 2015

We have provided the last update i,e 2 month’s back that to buy Dr. Reddy's Laboratories Limited share at 3350 level and target value was mentioned as 3500. Now current value has been increased as 3649 as said earlier.

Please find below link to check the trade value.

http://nseanalyst.blogspot.de/2015/02/stocks-to-watch.html

I hope everyone get good profit.

Stock update: ICICI Bank(Positional call)

About ICICI Bank:

ICICI Bank is India's largest private sector bank with total assets of Rs. 5,946.42 billion (US$ 99 billion) at March 31, 2014 and profit after tax Rs. 98.10 billion (US$ 1,637 million) for the year ended March 31, 2014.ICICI Bank currently has a network of 4,050 Branches and 12,642 ATM's across India. ICICI Bank is India's largest private sector bank with total assets of Rs. 5,946.42 billion (US$ 99 billion) at March 31, 2014 and profit after tax Rs. 98.10 billion (US$ 1,637 million) for the year ended March 31, 2014.ICICI Bank currently has a network of 4,050 Branches and 12,642 ATM's across India.

ICICI Bank provides a wide array of banking products and financial services to its retail and corporate customers. It has a wide variety of delivery channels and specialized affiliates and subsidiaries that ensure the flow of its offerings in the areas like investment banking, venture capital, life and non-life insurance and asset management. This bank is also India's largest credit card issuer. The equity share of ICICI Bank is listed on various stock exchanges like NSE, BSE, Kolkata Stock Exchange and Vadodara Stock Exchange etc. Its AD are also listed on the New York Stock 

Exchange .

BSE Code For this stock is 532174 and the NSE Code is ICICIBANK.

Latest announcement:

ICICI Bank Ltd has informed BSE that the Bank has allotted 523,100 equity shares of face value of Rs. 2/- each on May 11, 2015 under the Employees Stock Option Scheme, 2000 (ESOS).

ICICI Bank Investment today sold over 90.89 lakh shares in software solutions provider 3i InfotechBSE -9.90 % for Rs 3.59 crore through an open market transaction. According to bulk deal data available with the NSE, ICICI Bank (Investment) sold 90.89 lakh shares of 3i Infotech.
The shares were sold at an average price of Rs 3.95 apiece, valuing the transaction at Rs 3.59 crore.

Expected movement for this Month:

Buy:

ICICI Bank was last traded at Rs 317.45, up 2.88%. It is one of the biggest bank in India and good stock invest our money too. we can buy ICICI bank at current market price (317). We can buy this stock when ICICI Equity crosses 318.72 level. so my first target is 324.70 and second target is 326.20 (You can exit at this level). Finally my exit target for this month Buy is 329.

Please buy ICICI bank future  when ICICI bank equity crosses 318 level. Target is 326.

Short:

According to last month high and low, we can short this stock when it crosses 312.80.
 So my first target is 306.93, second target is 305.67 and exit target for short is 304.we can short the ICICI bank future at 312 level. Please find the below table.

Dr. Reddy's Quarter(Q4) Result Update:

Dr. Reddy's Laboratories reported 8 per cent annual growth in its consolidated net profit for the January-March on the back of strong growth in its revenues.The company had posted a net profit of Rs 481.60 crore for the corresponding period of previous fiscal year.Dr Reddy's Labs  has posted a consolidated net profit of Rs 519 crore in the quarter ended March 2015 up 7.8 percent from Rs 481.6 crore in the corresponding quarter last fiscal. During the period, total income was up 11.2 percent at Rs 3870 crore versus Rs 3481 crore (Y-o-Y) on consolidated basis

Dr. Reddy's Laboratories reported a net profit of Rs 519 crore over sales of Rs 3,870 crore in the quarter ended March 31, 2015. The pharma major had reported a net profit of Rs 482 crore on sales of Rs 3,480 crore in the corresponding quarter of last fiscal.   Its net profit at Rs 590 crore over sales of Rs 3,868 crore.

Dr. Reddy's net profit in the March quarter was impacted by forex losses of Rs 84.3 crore high research & development (R&D) expenses which came in at Rs 514 crore against Rs 398 crore year-on-year.

Operating profit (EBITDA) of the company came in at Rs 810 crore against Rs 781 crore year-on-year and its operating margin, a major of profitability declined 80 basis points annually to 21 per cent. Analysts had estimated its EBITDA margin at 22 per cent.

The loss was incurred due to net monetary assets in Venezuela as the Government had modified its currency exchange systems. Overall, the company faced currency volatility in some emerging markets. However, it had to bear lower tax expense at Rs 74.2 crore in the quarter against Rs 125.2 crore year-on-year. Consolidated operating profit was at Rs 612 crore versus Rs 585.6 crore (Y-o-Y) while operating margin was at 15.8 percent compared to 16.8 percent (Y-o-Y). Margins were also impacted due to higher research and development (R&D) costs. R&D expenses were up 29 percent Y-o-Y to Rs 514.4 crore versus Rs 398.5 crore (was up 45 percent Y-o-Y in Q3). It also contains an impairment loss of Rs 9.5 crore in R&D. For the full year, R&D expenses were up 41 percent at Rs 1740 crore Y-o-Y which is 11.8 percent of revenue compared to 9.4 percent in FY14.

In a separate filing, Dr Reddy's Laboratories said the Board has recommended a final dividend of Rs 20 (400 per cent) per equity share of Rs 5 face value, for the financial year. The company has declared a dividend of Rs 20 per share.

Stock update: BHEL (Positional call)

About BHEL:

BHEL is part of the Infrastructure sector in Indian share market. BHEL is an integrated power plant equipment manufacturer and It is one of the largest engineering and manufacturing company. BHEL engaged in the design, engineering, manufacture, construction, testing, commissioning and servicing of a wide range of products and services for the core sectors of the economy. Power, Transmission, Industry, Transportation (Railway), Renewable Energy, Oil & Gas and Defense with over 180 products offerings to meet the needs of these sectors.

BSE code for BHEL is 500103 and NSE code for this stock is BHEL.

  

Recent achievement:

Bharat Heavy Electricals Limited (BHEL) has successfully commissioned the first unit of 82.5 MW at the upcoming Shrinagar Hydro Electric Project (HEP) in Uttarakhand. The greenfield hydro electric project consisting of four units of 82.5 MW each is being set up by Alaknanda Hydro Power Corporation Limited (GVK Group). The project is located on the Alaknanda River (near the town of Shrinagar in Pauri Garhwal District of Uttarakhand), a major tributary of the Ganga River, a perennial river in Uttarakhand. The project is designed to utilise the waters of River Alaknanda by way of a diversion dam. Power generation from Shrinagar HEP is likely to result in reduction of greenhouse gas emissions.BHEL’s scope of work in the project includes design, manufacture, supply, installation and commissioning of 4 units of 82.5 MW Francis Turbines, Generators, Static Excitation System, Generator Transformer, Unit Transformer, Station Transformer, Main Inlet Valve, Digital Governors, Control & Monitoring System (SCADA), Busduct, associated station auxiliaries, 400 kV Switchyard and Electrical & Mechanical Balance of Plant (BOP)

BHEL is presently executing hydro electric projects of around 4,000 MW which are under various stages of implementation. Other hydro power projects under execution by BHEL in Uttarakhand include Lata Tapovan HEP (3x57 MW), Tapovan Vishnugarh HEP (4x130 MW), Vyasi HEP (2X60 MW) and Vishnugarh Pipalkoti HEP (4x111 MW). So far, more than 500 hydro generating sets of various ratings have been contracted on BHEL in India and abroad, with a cumulative capacity of more than 26,000 MW. Of these, equipment for about 5,000 MW generating capacity has been contracted outside India.

Expected movement for this Month:

BHEL was last traded at Rs 234.55 , up 1.41%.We can buy this stock when equity crosses at 236.05level. My first target for this stock is 241.20 and my exit target for this month is 245.Please hold this stocks till expiry. It will be touch 250 levels very soon as It got many project from some state. Bhel has been consolidating for long between 225 – 235 levels. Now it can move up anytime. Buy for short term target of 250.

According to the last month High and low value, If it crosses 236.05 level then it will surely touch 243.80.

Tips to buy:

Lot size for BHEL is 1000. 

Buy 1 lot of future when bhel equity crosses 236.05 level and wait till this month expiry. And target for this month is 250.

Stock update: Tatamotors (Positional call)

About Tatamotors:

Tata Motors Limited is India's largest automobile company, with consolidated revenues of INR 2,32,834 crores (USD 38.9 billion) in 2013-14. Through subsidiaries and associate companies, Tata Motors has operations in the UK, South Korea, Thailand, South Africa and Indonesia. Among them is Jaguar Land Rover, the business comprising the two iconic British brands. It also has an industrial joint venture with Fiat in India.  With over 8 million Tata vehicles plying in India, Tata Motors is the country's market leader in commercial vehicles and among the top in passenger vehicles. Tata cars, buses and trucks are being marketed in several countries in Europe, Africa, the Middle East, South Asia, South East Asia, South America, CIS and Russia.

BSE Code for TATAMOTORS is  500570 and the NSE Code for this stock is TATAMOTORS

Latest announcement:

Tata Motors Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2015, inter alia, to consider the Audited Financial Results and the dividend, if any, for the financial year ended March 31, 2015.

Tata Motors Limited  announced the closing of its Rs. 7,500 crore rights issue offer period on May 2, 2015. Tata Motors offered up to 15,06,44,759 Ordinary Shares of face value Rs. 2 for cash at a price of Rs.450 (including a premium of Rs. 448) each in the ratio of 6 Ordinary Shares for every 109 fully paid-up Ordinary Shares and up to 2,65,30,290 ‘A’ Ordinary Shares of face value Rs. 2 at a price of Rs. 271 (including a premium of Rs. 269) each in the ratio of 6 ‘A’ Ordinary Shares for every 109 fully paid-up ‘A’ Ordinary Shares, in each case on a rights basis to eligible shareholders in respect of shares held on the Book Closure Date of April 8, 2015. The Share Issue commenced on April 17, 2014 and closed on May 2, 2015. Tata Motors also facilitated participation in the Share Issue by eligible holders of its American Depositary Shares by offering up to 64,09,964 American Depositary Shares, each representing 5 Ordinary Shares (“ADSs”), at a price of US$39.42 per ADS at the rate of 0.055045 ADS rights for each ADS held as of the close of business on April 7, 2015 (New York City time).

 Expected movement for this Month:

TataMotors was last traded at Rs 529.65, up 3.15%.Tatamotors is the biggest and good stock for invest our money and we are expecting very good Q 4 result for this stock. We can buy this stock at current level. When Tatamotors equity Crosses 544.01 it strongly indicate upper trend. So buy this stock at that level. My first target for this month is 551.81. second target is 553.77. And my exit target for this moth will be 555.73

Tips to buy:

Lot size of Tatamotors is 500.

Buy 1 lot of future when equity crosses 544.01. Please wait till expiry Target for this month is 555.73.